Journal of Clinical Endocrinology & Metabolism, Vol 80, 3596-3600, Copyright © 1995 by Endocrine Society

ARTICLES

Adult height in short normal adolescent girls treated with gonadotropin- releasing hormone analog and growth hormone

R Balducci, V Toscano, A Mangiantini, G Municchi, F Vaccaro, S Picone, A Di Rito and B Boscherini
Department of Pediatrics, University Tor Vergata, Rome, Italy.

GnRH analog associated with GH therapy has potential importance for treatment of short stature in subjects without GH deficiency and with a normal onset of puberty. We treated 10 girls with familial short stature with the GnRH analog leuprolide (3.75 mg, im, every 25 days) and GH (0.1 IU/kg.day, sc, 6 days/week). The combined therapies were started simultaneously, and the patients were treated for 28.1 +/- 5.4 (range, 24-36) months. At the onset of treatment, chronological age was 11.6 +/- 1.4 yr, bone age was 10.6 +/- 0.9 yr, height was -2.7 +/- 0.7 SD, predicted height (PH; Bayley-Pinneau score) was 143.2 +/- 3 cm. Target height was 147.6 +/- 5.6 cm. Tanner stage was II-III for breast and genitalia. During treatment, puberty was completely suppressed in all patients. Statistical analysis was performed using Student's t test for paired data. After 12 months of treatment, we observed a significant (P < 0.02) improvement of predicted height (146.2 +/- 3.4 cm). This improvement remained significant (147.6 +/- 3.5; P < 0.001) when treatment was withdrawn. At that time, chronological age was 13.9 +/- 1.2 yr, and bone age was 12.4 +/- 0.7 yr. At the present time (3 +/- 0.97 yr after discontinuation), all of the girls have reached a final height of 144.6 +/- 3 cm (range, 140-149.3 cm). The final height is not significantly different compared with the PH at the beginning of treatment or with target height. These data show that in our patients, combined treatment with GnRH analog and GH, despite a significant improvement in PH during therapy and upon its withdrawal, does not result in a significant increase in adult stature. Larger and perhaps more prolonged studies in patients of both sexes are required to reach definitive conclusions. Nevertheless, the cost of this treatment in terms of both subject compliance and economic cost should be weighed against the small height gain, if any, that may be achieved.

This article has been cited by other articles:

				N. Mauras, L. Gonzalez de Pijem, H. Y. Hsiang, P. Desrosiers, R. Rapaport, I. D. Schwartz, K. O. Klein, R. J. Singh, A. Miyamoto, and K. Bishop Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated with Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 823 - 831. [Abstract] [Full Text] [PDF]

				S. A. van Gool, G. A. Kamp, H. Visser-van Balen, D. Mul, J. J. J. Waelkens, M. Jansen, L. Verhoeven-Wind, H. A. Delemarre-van de Waal, S. M. P. F. de Muinck Keizer-Schrama, G. Leusink, et al. Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1402 - 1408. [Abstract] [Full Text] [PDF]

				M. Maghnie, L. Ambrosini, M. Cappa, G. Pozzobon, L. Ghizzoni, M. G. Ubertini, N. di Iorgi, C. Tinelli, S. Pilia, G. Chiumello, et al. Adult Height in Patients with Permanent Growth Hormone Deficiency with and without Multiple Pituitary Hormone Deficiencies J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2900 - 2905. [Abstract] [Full Text] [PDF]

				J. A. Yanovski, S. R. Rose, G. Municchi, O. H. Pescovitz, S. C. Hill, F. G. Cassorla, and G. B. Cutler Jr. Treatment with a Luteinizing Hormone-Releasing Hormone Agonist in Adolescents with Short Stature N. Engl. J. Med., March 6, 2003; 348(10): 908 - 917. [Abstract] [Full Text] [PDF]

				W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF]

				P. B. Kaplowitz If Gonadotropin-Releasing Hormone Plus Growth Hormone (GH) Really Improves Growth Outcomes in Short Non-GH-Deficient Children, Then What? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2965 - 2968. [Full Text] [PDF]

				G. A. Kamp, D. Mul, J. J. J. Waelkens, M. Jansen, H. A. Delemarre-van de Waal, L. Verhoeven-Wind, M. Frolich, W. Oostdijk, and J. M. Wit A Randomized Controlled Trial of Three Years Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Children with Idiopathic Short Stature and Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2969 - 2975. [Abstract] [Full Text] [PDF]

				J. B. Q. Quintos, M. G. Vogiatzi, M. D. Harbison, and M. I. New Growth Hormone Therapy Alone or in Combination with Gonadotropin-Releasing Hormone Analog Therapy to Improve the Height Deficit in Children with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1511 - 1517. [Abstract] [Full Text]

				R. Lanes and P. Gunczler Final Adult Height in Short Healthy Children Treated with Growth Hormone and Gonadotropin-Releasing Hormone Analogs J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 458 - 458. [Full Text]

				N. Mauras, K. M. Attie, E. O. Reiter, P. Saenger, and J. Baptista the Genentech Inc. Cooperative Study Grou High Dose Recombinant Human Growth Hormone (GH) Treatment of GH-Deficient Patients in Puberty Increases Near-Final Height: A Randomized, Multicenter Trial J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3653 - 3660. [Abstract] [Full Text]

				A. M. Pasquino, I. Pucarelli, M. Roggini, and M. Segni Adult Height in Short Normal Girls Treated with Gonadotropin-Releasing Hormone Analogs and Growth Hormone J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 619 - 622. [Abstract] [Full Text]

				B. Kohn, J. R. Julius, and S. L. Blethen Combined Use of Growth Hormone and Gonadotropin-releasing Hormone Analogues: The National Cooperative Growth Study Experience Pediatrics, October 1, 1999; 104(4): 1014 - 1018. [Abstract] [Full Text]

				F. R. Kaufman and J. P. Sy Regular Monitoring of Bone Age Is Useful in Children Treated With Growth Hormone Pediatrics, October 1, 1999; 104(4): 1039 - 1042. [Abstract] [Full Text]

				A. M. Pasquino, I. Pucarelli, M. Segni, M. Matrunola, and F. Cerrone Adult Height in Girls with Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues and Growth Hormone J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 449 - 452. [Abstract] [Full Text]

				J. L. Walker, P. A. Crock, S. N. Behncken, S. W. Rowlinson, L. M. Nicholson, T. J. C. Boulton, and M. J. Waters A Novel Mutation Affecting the Interdomain Link Region of the Growth Hormone Receptor in a Vietnamese Girl, and Response to Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor-I and Luteinizing Hormone-Releasing Hormone Analogue J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2554 - 2561. [Abstract] [Full Text]